Business Context and Reporting Period
Company: Neuralstem, Inc. (Note: Metadata referenced "Palisade Bio, Inc." but the filing text identifies the registrant as Neuralstem, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2016
Reporting Period: Three and nine months ended September 30, 2016
The filing serves as a notification that the Company reported financial results and provided updates on clinical programs and business highlights via a press release attached as Exhibit 99.01.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data. The following metrics are referenced as being reported in the attached press release but are not detailed in this document:
- Revenue: Not provided in text.
- Profit/Loss: Not provided in text.
- Cash Flow: Not provided in text.
- Margins: Not provided in text.
- Debt and Liquidity: Not provided in text.
Material Changes
The filing text does not provide specific comparative data or quantify material changes versus prior periods. It only states that results for the three and nine months ended September 30, 2016, were reported.
Guidance, Outlook, and Risks
Management Commentary: The Company provided an update on clinical programs and business highlights in the referenced press release.
Legal Disclaimer: The information furnished under Item 2.02 and Exhibit 99.01 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It is not incorporated by reference into subsequent filings unless specifically stated.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Press Release (Exhibit 99.01) as they are absent from the 8-K cover sheet.
- Review the clinical program updates and business highlights detailed in the press release for operational progress.
- Confirm the registrant name is Neuralstem, Inc., noting the discrepancy with the metadata label "Palisade Bio, Inc."
- Check for any forward-looking statements in the press release that may carry standard risk disclaimers.